Permanent chemotherapy-induced alopecia in breast cancer patients: A 3-year prospective cohort study

Permanent chemotherapy-induced alopecia in breast cancer patients: A 3-year prospective cohort study is organized by Society for Translational Oncology (STO) and will be held from Apr 15, 2019 - Apr 15, 2021. This Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credit™.

Target Audience:
Physicians who wish to advance their current knowledge of symptom management and supportive care.

Learning Objectives:
• Estimate the long-term incidence of permanent chemotherapy induced alopecia (PCIA) among breast cancer patients.
• Identify risk factors of PCIA.
• Evaluate the impact of PCIA on patients’ body image.

Additional details will be posted as soon as they are available.